82019-89-4 Usage
Uses
Used in Pharmaceutical Industry:
2-CHLOROISONICOTINIMIDAMIDE HYDROCHLORIDE is used as a building block for the synthesis of various drugs due to its unique chemical structure and reactivity, contributing to the development of new therapeutic agents.
Used in Antifungal and Antibacterial Applications:
In the medical field, 2-CHLOROISONICOTINIMIDAMIDE HYDROCHLORIDE is used as an antifungal and antibacterial agent, leveraging its potential to combat infections caused by fungi and bacteria.
Used in Research and Development:
2-CHLOROISONICOTINIMIDAMIDE HYDROCHLORIDE is utilized in research for its potential application in treating various medical conditions, indicating its versatility and importance in pharmaceutical innovation.
Used in Agrochemical Industry:
In the production of pesticides and other agrochemicals, 2-CHLOROISONICOTINIMIDAMIDE HYDROCHLORIDE is used as a key component, highlighting its role in developing effective solutions for agricultural challenges.
Safety and Handling:
2-CHLOROISONICOTINIMIDAMIDE HYDROCHLORIDE is handled and stored following standard safety protocols for hazardous substances, ensuring the protection of workers and the environment during its use in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 82019-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,0,1 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 82019-89:
(7*8)+(6*2)+(5*0)+(4*1)+(3*9)+(2*8)+(1*9)=124
124 % 10 = 4
So 82019-89-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H6ClN3.ClH/c7-5-3-4(6(8)9)1-2-10-5;/h1-3H,(H3,8,9);1H
82019-89-4Relevant academic research and scientific papers
INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS
-
Page/Page column 48, (2011/10/03)
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved.
